As such, it was speculated that induction of angiogenesis via Shh may mediate VEGF-independent neovascularization in pancreatic cancer, thereby serving as a potential mechanism for resistance to anti-VEGF therapy (Mizukami, 2012). The gene discussed is VEGFA; the disease is familial pancreatic carcinoma.